Literature DB >> 8961275

Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin alpha-subunit gene.

K Kananen1, M Markkula, M Mikola, E M Rainio, A McNeilly, I Huhtaniemi.   

Abstract

We have developed a transgenic (TG) mouse model for gonadal tumorigenesis expressing the Simian virus 40 T-antigen (Tag) under the mouse inhibin alpha-subunit promoter. Gonadal tumors appear with 100% penetrance by the age of 5-8 months in the TG mice. When 1-month-old TG mice were gonadectomized, adrenal gland tumors were observed in each animal (12 females, 11 males) at the age of 6-8 months. No adrenal tumors were detected in gonadectomized non-TG mice (nine females, nine males) or in the intact TG mice (n > 100). The tumors appeared to originate from the X zone of the adrenal cortex. The TG mice with adrenocortical tumors had elevated serum levels of progesterone, estradiol, and immunoreactive inhibin (including dimeric forms), but corticosterone secretion was reduced. The lack of adrenal tumors in intact TG mice suggested that the tumorous gonads secrete factor(s) inhibiting adrenal tumorigenesis. As a candidate molecule, we studied the effects of inhibin, which was high in the serum of control females and TG females with ovarian tumors, as well as in TG males with testicular tumors. The DNA synthesis, as well as the levels of inhibin-alpha and Tag mRNA expression, were significantly reduced by recombinant human inhibin A in cell cultures derived from the adrenal tumors. In accordance, the expression level of inhibin-alpha mRNA in the normal adrenal gland was elevated 2 weeks after gonadectomy. These findings suggest that gonadal inhibin can down-regulate the expression of the inhibin alpha-subunit gene in the adrenal gland. When circulating inhibin is eliminated by gonadectomy, Tag expression and tumorigenesis are stimulated in the adrenal glands of the TG mice. The results demonstrate a novel mechanism of autoregulation in inhibin alpha-subunit gene expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8961275     DOI: 10.1210/mend.10.12.8961275

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  20 in total

1.  A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.

Authors:  Gabriel Bodek; Susanna Vierre; Adolfo Rivero-Müller; Ilpo Huhtaniemi; Adam J Ziecik; Nafis A Rahman
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

Review 2.  Adrenocortical stem and progenitor cells: unifying model of two proposed origins.

Authors:  Michelle A Wood; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2010-11-20       Impact factor: 4.102

Review 3.  Role of the GATA family of transcription factors in endocrine development, function, and disease.

Authors:  Robert S Viger; Séverine Mazaud Guittot; Mikko Anttonen; David B Wilson; Markku Heikinheimo
Journal:  Mol Endocrinol       Date:  2008-01-03

4.  A Novel Population of Inner Cortical Cells in the Adrenal Gland That Displays Sexually Dimorphic Expression of Thyroid Hormone Receptor-β1.

Authors:  Chen-Che Jeff Huang; Cary Kraft; Nicole Moy; Lily Ng; Douglas Forrest
Journal:  Endocrinology       Date:  2015-03-16       Impact factor: 4.736

5.  Testosterone-secreting gonadotropin-responsive adrenal adenoma and its treatment with the antiandrogen flutamide.

Authors:  F A Lószió; S Tóth; J Kocsis; M Szécsi
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

6.  P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model.

Authors:  M Batisse-Lignier; I Sahut-Barnola; F Tissier; T Dumontet; M Mathieu; C Drelon; J-C Pointud; C Damon-Soubeyrand; G Marceau; J-L Kemeny; J Bertherat; I Tauveron; P Val; A Martinez; A-M Lefrançois-Martinez
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

7.  Animal models of adrenocortical tumorigenesis.

Authors:  Felix Beuschlein; Sara Galac; David B Wilson
Journal:  Mol Cell Endocrinol       Date:  2011-11-11       Impact factor: 4.102

8.  Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice.

Authors:  Isabelle Sahut-Barnola; Cyrille de Joussineau; Pierre Val; Sarah Lambert-Langlais; Christelle Damon; Anne-Marie Lefrançois-Martinez; Jean-Christophe Pointud; Geoffroy Marceau; Vincent Sapin; Frédérique Tissier; Bruno Ragazzon; Jérôme Bertherat; Lawrence S Kirschner; Constantine A Stratakis; Antoine Martinez
Journal:  PLoS Genet       Date:  2010-06-10       Impact factor: 5.917

9.  Transgenic GATA-4 expression induces adrenocortical tumorigenesis in C57Bl/6 mice.

Authors:  Marcin Chrusciel; Susanna Vuorenoja; Bidut Mohanty; Adolfo Rivero-Müller; Xiangdong Li; Jorma Toppari; Ilpo Huhtaniemi; Nafis A Rahman
Journal:  J Cell Sci       Date:  2013-02-26       Impact factor: 5.285

Review 10.  In search of adrenocortical stem and progenitor cells.

Authors:  Alex C Kim; Ferdous M Barlaskar; Joanne H Heaton; Tobias Else; Victoria R Kelly; Kenneth T Krill; Joshua O Scheys; Derek P Simon; Alessia Trovato; Wei-Hsiung Yang; Gary D Hammer
Journal:  Endocr Rev       Date:  2009-04-29       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.